Who is sponsoring NCT05306886?

NCT05306886 is sponsored by Abant Izzet Baysal University.

What drugs are being tested in NCT05306886?

Interventions in NCT05306886: ICB Medical Insoles, ICM Insoles.

What condition does NCT05306886 study?

NCT05306886 studies Flat Foot [Pes Planus] (Acquired), Unspecified Foot.

Is NCT05306886 still recruiting?

NCT05306886 is currently completed. Last updated 22 April 2024.

Last reviewed 2024-04-22 · How we verify

NCT05306886

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Investigation of the Effect of Specially Designed Insoles for Flat-footed Patients

Completed NA Last updated 22 April 2024

What this trial tests

NA trial testing ICB Medical Insoles in Flat Foot [Pes Planus] (Acquired), Unspecified Foot in 45 participants. Completed in 16 June 2023.

Timeline

1 March 2022

Primary endpoint
15 June 2023

16 June 2023

Quick facts

Lead sponsor	Abant Izzet Baysal University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	45
Start date	1 March 2022
Primary completion	15 June 2023
Estimated completion	16 June 2023
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

ICB Medical Insoles
ICM Insoles

Conditions studied

Flat Foot [Pes Planus] (Acquired), Unspecified Foot — all drugs for Flat Foot [Pes Planus] (Acquired), Unspecified Foot →

Sponsor

Abant Izzet Baysal University

Who can join

Adults 18 to 45, any sex, with Flat Foot [Pes Planus] (Acquired), Unspecified Foot. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In our study, it was aimed to investigate the effect of insoles specially designed for each patient and printed with 3D printers on the physical activity levels, balance and functional performances of those patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Abant Izzet Baysal University trials

Trials by the same sponsor.

NCT07374744 — Effect of Interactive Video-Based Self-Management Education in Adults With Type 2 Diabetes · NA · not yet recruiting
NCT07524790 — The Effect of Proprioceptive Neuromuscular Facilitation on Haemodynamic Responses in a Neurological Intensive Care · NA · not yet recruiting
NCT07507721 — Tele-Nursing-Supported Mindfetalness: Anxiety and Prenatal Attachment · NA · not yet recruiting
NCT07509021 — Neuropathic Pain, Catastrophizing, and Adherence in SAIS · recruiting
NCT07535177 — Gas6 and Soluble MerTK in Periodontal Diseases · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05306886 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Abant Izzet Baysal University
Last refreshed: 22 April 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05306886.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing